Trial Profile
A Multicentre, Open-label, Single-group Maximal Use Trial, Evaluating the Safety and Pharmacokinetic Profile of the Active Ingredients and Their Metabolites After Application of MC2-01 Cream in Adolescents With Extensive Psoriasis Vulgaris
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 24 Dec 2021
Price :
$35
*
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary) ; Betamethasone-dipropionate/calcipotriol (Primary)
- Indications Plaque psoriasis
- Focus Pharmacodynamics
- Sponsors MC2 Therapeutics
- 20 Dec 2021 This trial has been completed in Hungary (end date: 2020-05-27) according to European Clinical Trials Database record.
- 07 Mar 2021 This trial has been completed in Czech Republic, according to European Clinical Trials Database record. (Global end date:2020-12-11)
- 01 Feb 2021 Status changed from active, no longer recruiting to discontinued due to lack of recruitment.